These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11000570)

  • 1. The biological basis for antiangiogenic therapy.
    Giavazzi R; Albini A; Bussolino F; DeBraud F; Presta M; Ziche M; Costa A
    Eur J Cancer; 2000 Oct; 36(15):1913-8. PubMed ID: 11000570
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticancer therapy with angiogenesis inhibitors.
    Ghilardi C; Bani MR; Giavazzi R
    Tumori; 2001; 87(6):S14-6. PubMed ID: 11989610
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of angiogenesis via vascular endothelial growth factor receptors.
    Veikkola T; Karkkainen M; Claesson-Welsh L; Alitalo K
    Cancer Res; 2000 Jan; 60(2):203-12. PubMed ID: 10667560
    [No Abstract]   [Full Text] [Related]  

  • 4. VEGF receptor signaling in tumor angiogenesis.
    McMahon G
    Oncologist; 2000; 5 Suppl 1():3-10. PubMed ID: 10804084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiogenesis and tumor growth. Angiogenic factors and tumor growth].
    Plouet J
    Ann Pathol; 1999; 19(5 Suppl):S70-1. PubMed ID: 10599456
    [No Abstract]   [Full Text] [Related]  

  • 6. [New molecular target of cancer therapy--angiogenesis regulator VEGF].
    Toi M; Ueno T; Tominaga T
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2202-6. PubMed ID: 9422062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities.
    Siemeister G; Martiny-Baron G; Marmé D
    Cancer Metastasis Rev; 1998 Jun; 17(2):241-8. PubMed ID: 9770121
    [No Abstract]   [Full Text] [Related]  

  • 8. Vascular endothelial growth factor: basic biology and clinical implications.
    Ferrara N; Keyt B
    EXS; 1997; 79():209-32. PubMed ID: 9002234
    [No Abstract]   [Full Text] [Related]  

  • 9. Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications.
    Ellis LM; Takahashi Y; Liu W; Shaheen RM
    Oncologist; 2000; 5 Suppl 1():11-5. PubMed ID: 10804085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of blood vessel growth by vascular endothelial growth factor.
    Ferrara N; Heinsohn H; Walder CE; Bunting S; Thomas GR
    Ann N Y Acad Sci; 1995 Mar; 752():246-56. PubMed ID: 7538737
    [No Abstract]   [Full Text] [Related]  

  • 13. Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects.
    Sledge GW
    Semin Oncol; 2002 Jun; 29(3 Suppl 11):104-10. PubMed ID: 12138404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF in brain tumors.
    Machein MR; Plate KH
    J Neurooncol; 2000; 50(1-2):109-20. PubMed ID: 11245271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies.
    Aiello LP
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1647-52. PubMed ID: 9286253
    [No Abstract]   [Full Text] [Related]  

  • 16. VEGF as a mediator of tumor-associated immunodeficiency.
    Ohm JE; Carbone DP
    Immunol Res; 2001; 23(2-3):263-72. PubMed ID: 11444391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symposium on molecular pathogenesis of respiratory diseases and its clinical implication. 4. Molecular pathogenesis of lung cancer and its molecular targeted therapy.
    Sone S; Shinohara T; Nishioka Y; Yano S
    Intern Med; 2001 Feb; 40(2):167-70. PubMed ID: 11300157
    [No Abstract]   [Full Text] [Related]  

  • 18. Rocking the foundations of solid tumor growth by attacking the tumor's blood supply.
    Molema G; Griffioen AW
    Immunol Today; 1998 Sep; 19(9):392-4. PubMed ID: 9745201
    [No Abstract]   [Full Text] [Related]  

  • 19. Control of tumor growth via inhibition of tumor angiogenesis.
    Plate KH
    Adv Exp Med Biol; 1998; 451():57-61. PubMed ID: 10026850
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development.
    Carmeliet P; Collen D
    Curr Top Microbiol Immunol; 1999; 237():133-58. PubMed ID: 9893349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.